Company Filing History:
Years Active: 2012-2025
Title: Innovations of Tai Chi Cheuk in Cancer Treatment
Introduction
Tai Chi Cheuk is a prominent inventor based in Germantown, MD (US). He has made significant contributions to the field of cancer research through his innovative work on monoclonal antibodies. With a total of 3 patents, his inventions focus on targeting specific cancer receptors to improve diagnosis and treatment options.
Latest Patents
Tai Chi Cheuk's latest patents include groundbreaking work on monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4). These antibodies are selected from immunized mice, immunized rabbits, and a human scFv library. They specifically bind to FGFR4, which is crucial for the development of various cancer therapies. The patents also describe chimeric antigen receptors, antibody-drug conjugates, immunoconjugates, bispecific antibodies, and immunoliposomes that incorporate FGFR4-specific antibodies. These antibody compositions can be utilized to diagnose or treat FGFR4-positive cancers, including rhabdomyosarcoma, lung cancer, liver cancer, breast cancer, pancreatic cancer, and prostate cancer.
Career Highlights
Tai Chi Cheuk is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on innovative cancer therapies and contribute to the advancement of medical science.
Collaborations
Some of his notable coworkers include Javed Khan and Sivasubramanian Baskar. Their collaborative efforts have further enhanced the research and development of effective cancer treatments.
Conclusion
Tai Chi Cheuk's innovative work in developing monoclonal antibodies for cancer treatment showcases his dedication to improving patient outcomes. His contributions to the field are invaluable and continue to pave the way for future advancements in cancer therapy.